Ctt Pharmaceutical Holdings annual ebitda
2010
2011
2024
2025
Ctt Pharmaceutical Holdings EBITDA Growth & History (CTTH)
Ctt Pharmaceutical Holdings's calculated EBITDA was −$147,594 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$147,594 | $96,237 | — |
| 2024 | 2024-12-31 | −$243,831 | — | — |
| 2011 | 2011-12-31 | −$757,935 | $1.2M | — |
| 2010 | 2010-12-31 | −$2.0M | — | — |
Ctt Pharmaceutical Holdings quarterly ebitda
Q2.10
Q3.10
Q3.11
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$12,903 | $46,226 | — |
| Q1 2026 | 2026-03-31 | −$82,971 | −$55,027 | — |
| Q4 2025 | 2025-12-31 | −$46,742 | — | — |
| Q3 2025 | 2025-09-30 | −$13,779 | — | — |
| Q2 2025 | 2025-06-30 | −$59,129 | — | — |
| Q1 2025 | 2025-03-31 | −$27,944 | — | — |
| Q3 2011 | 2011-09-30 | −$107,420 | $849,703 | — |
| Q3 2010 | 2010-09-30 | −$957,123 | — | — |
| Q2 2010 | 2010-06-30 | −$361,115 | — | — |
Ctt Pharmaceutical Holdings ebitda trends
Between the periods ended 2010-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's ebitda increased from −$2.0M to −$147,594, a change of $1.9M. The latest reported quarter, Q2 2026, shows −$12,903.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗